Brief: Bioventus Q3 Adjusted EPS USD 0.06
05/11/2024 12:30
Nov 05 (Reuters) - Bioventus Q3 sales USD 139 million. * Q3 adjusted EBITDA USD 23.6 million * outlook FY sales USD 562-567 million
Recent news on Bioventus
See all newsBioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks
U.S. STOCKS ON THE MOVE-American Eagle Outfitters, gold miners, EPAM
U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus
Bioventus rises after better-than-expected quarterly results